Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance.

Source:http://linkedlifedata.com/resource/pubmed/id/20008624

J. Clin. Oncol. 2010 Jan 20 28 3 453-9

Download in:

View as

Triples

General Info

PMID
20008624